Membership
Tour
Register
Log in
HETEROCYCLIC COMPOUNDS
Follow
Industry
CPC
C07D
Parent Industries
C
CHEMISTRY METALLURGY
C07
Organic chemistry
Current Industry
C07D
HETEROCYCLIC COMPOUNDS
Sub Industries
C07D201/00
Preparation, separation, purification or stabilisation of unsubstituted lactams
C07D203/00
Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
C07D205/00
Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
C07D207/00
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/00
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D211/00
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D213/00
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D215/00
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D217/00
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
C07D219/00
Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
C07D221/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
C07D223/00
Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
C07D225/00
Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
C07D227/00
Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
C07D229/00
Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
C07D231/00
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D233/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
C07D235/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
C07D237/00
Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
C07D239/00
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
C07D241/00
Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
C07D243/00
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
C07D245/00
Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
C07D247/00
Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
C07D249/00
Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D251/00
Heterocyclic compounds containing 1,3,5-triazine rings
C07D253/00
Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
C07D255/00
Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
C07D257/00
Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
C07D259/00
Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
C07D261/00
Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D263/00
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
C07D265/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D267/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D269/00
Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
C07D271/00
Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
C07D273/00
Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
C07D275/00
Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
C07D277/00
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
C07D279/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D281/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D283/00
Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00
C07D285/00
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
C07D291/00
Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
C07D293/00
Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
C07D295/00
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D301/00
Preparation of oxiranes
C07D303/00
Compounds containing three-membered rings having one oxygen atom as the only ring heteroatom
C07D305/00
Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atom
C07D307/00
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
C07D309/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
C07D311/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
C07D313/00
Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
C07D315/00
Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
C07D317/00
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
C07D319/00
Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
C07D321/00
Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
C07D323/00
Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
C07D325/00
Heterocyclic compounds containing rings having oxygen as the only ring hetero atoms according to more than one of the main groups C07D303/00 - C07D323/00
C07D327/00
Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
C07D329/00
Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms
C07D331/00
Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
C07D333/00
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D335/00
Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
C07D337/00
Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
C07D339/00
Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
C07D341/00
Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
C07D343/00
Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms
C07D345/00
Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms
C07D347/00
Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms
C07D401/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D403/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D405/00
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D407/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
C07D409/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D411/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D413/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D415/00
Heterocyclic compounds containing the thiamine skeleton
C07D417/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
C07D419/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
C07D421/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
C07D451/00
Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems
C07D453/00
Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems
C07D455/00
Heterocyclic compounds containing quinolizine ring systems
C07D457/00
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems
C07D459/00
Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems
C07D461/00
Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems
C07D463/00
Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D471/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
C07D473/00
Heterocyclic compounds containing purine ring systems
C07D475/00
Heterocyclic compounds containing pteridine ring systems
C07D477/00
Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , carbapenicillins, thienamycins Such ring systems being further condensed
C07D487/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
C07D489/00
Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems
C07D491/00
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
C07D493/00
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
C07D495/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
C07D497/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D498/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D499/00
Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D501/00
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D503/00
Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D505/00
Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D507/00
Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D505/00 Such ring systems being further condensed
C07D513/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D515/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D517/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium or halogen atoms as ring hetero atoms
C07D519/00
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
C07D521/00
Heterocyclic compounds containing unspecified hetero rings
Industries
Overview
Organizations
People
Information
Impact
Please log in for detailed analytics
Patents Grants
last 30 patents
Information
Patent Grant
Positive resist composition and patterning process
Patent number
12,204,245
Issue date
Jan 21, 2025
Shin-Etsu Chemical Co., Ltd.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Method for producing aromatic nitrile compound and method for produ...
Patent number
12,202,786
Issue date
Jan 21, 2025
Mitsubishi Gas Chemical Company, Inc.
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
Antimicrobial compounds, compositions, and articles of manufacture...
Patent number
12,202,798
Issue date
Jan 21, 2025
CFD Research Corporation
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Grant
Small molecules for treating cancer, inhibiting chemokine activity...
Patent number
12,202,803
Issue date
Jan 21, 2025
AlonBio Ltd.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Glycosyl donor, preparation method therefor, and use thereof
Patent number
12,202,812
Issue date
Jan 21, 2025
Sichuan University
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Heterocyclic compound and organic light emitting device comprising...
Patent number
12,202,838
Issue date
Jan 21, 2025
LG Chem, Ltd.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
In-flow photooxygenation of aminothienopyridinones generates PTP4A3...
Patent number
12,202,839
Issue date
Jan 21, 2025
University of Virginia Patent Foundation
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
MCL1 inhibitors
Patent number
12,202,842
Issue date
Jan 21, 2025
Gilead Sciences, Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Ras inhibitors
Patent number
12,202,845
Issue date
Jan 21, 2025
Revolution Medicines, Inc.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Organic electroluminescent materials and devices
Patent number
12,207,550
Issue date
Jan 21, 2025
Beijing Summer Sprout Technology Co., Ltd.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Processes and intermediates for preparing MCL1 inhibitors
Patent number
12,202,782
Issue date
Jan 21, 2025
Gilead Sciences, Inc.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Gas-phase homogeneous oxidative dehydrogenation and coupling of org...
Patent number
12,202,795
Issue date
Jan 21, 2025
Trustees of Tufts College
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
Method for producing pyrrole compound
Patent number
12,202,797
Issue date
Jan 21, 2025
Takeda Pharmaceutical Company Limited
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Grant
4-cyano-1-(2-oxo-2-(substituted phenyl) ethyl) pyridin-1-ium bromid...
Patent number
12,202,801
Issue date
Jan 21, 2025
KING FAISAL UNIVERSITY
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-ch...
Patent number
12,202,805
Issue date
Jan 21, 2025
Bayer Aktiengesellschaft
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compounds for treating prostate cancer
Patent number
12,202,811
Issue date
Jan 21, 2025
University of Pittsburgh of the Commonwealth System of Higher Education
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compounds as NADPH oxidase inhibitors
Patent number
12,202,816
Issue date
Jan 21, 2025
CALLIDITAS THERAPEUTICS SUISSE SA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compounds and methods for CD73 modulation and indications therefor
Patent number
12,202,818
Issue date
Jan 21, 2025
OPNA BIO SA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Pyridazinone compounds and uses thereof
Patent number
12,202,819
Issue date
Jan 21, 2025
Edgewise Therapeutics, Inc.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Addition salt of S1P1 receptor agonist and crystal form thereof, an...
Patent number
12,202,822
Issue date
Jan 21, 2025
SuZhou Connect Biopharmaceuticals, Inc.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
1,3,4-oxadiazole derivatives as histone deacetylase inhibitors
Patent number
12,202,823
Issue date
Jan 21, 2025
QUIMATRYX, S.L.
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Pyrimidine compounds and use thereof
Patent number
12,202,825
Issue date
Jan 21, 2025
National Health Research Institutes
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Bicyclic heterocycle compounds and their uses in therapy
Patent number
12,202,828
Issue date
Jan 21, 2025
Astex Therapeutics Limited
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Small molecule inhibitors of the JAK family of kinases
Patent number
12,202,831
Issue date
Jan 21, 2025
JANSSEN PHARMACEUTICA NV
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Therapeutic agents for enhancing epithelial and/or endothelial barr...
Patent number
12,202,841
Issue date
Jan 21, 2025
ARTUS THERAPEUTICS, INC.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Muscarinic receptor agonists
Patent number
12,202,843
Issue date
Jan 21, 2025
Nxera Pharma UK Limited
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
MAP4K1 inhibitors
Patent number
12,202,844
Issue date
Jan 21, 2025
Blueprint Medicines Corporation
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compositions and coatings with non-chrome corrosion inhibitor parti...
Patent number
12,203,004
Issue date
Jan 21, 2025
The Boeing Company
C23 - COATING METALLIC MATERIAL COATING MATERIAL WITH METALLIC MATERIAL CHEMI...
Information
Patent Grant
Sulfoperoxycarboxylic acids, their preparation and methods of use a...
Patent number
12,203,056
Issue date
Jan 21, 2025
Ecolab USA Inc.
C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...
Information
Patent Grant
Bicyclic compound and use thereof for medical purposes
Patent number
12,201,603
Issue date
Jan 21, 2025
Ono Pharmaceutical Co., Ltd.
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
ADDITIVES FOR ELECTROLYTES IN Li-ION BATTERIES
Publication number
20250023099
Publication date
Jan 16, 2025
HYDRO-QUEBEC
Charlotte MALLET
H01 - BASIC ELECTRIC ELEMENTS
Information
Patent Application
NOVEL QUINIZARIN DERIVATIVE AND PREPARATION METHOD THEREOF
Publication number
20250019335
Publication date
Jan 16, 2025
BENOBIO CO., LTD.
In-Hyun LEE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME
Publication number
20250019340
Publication date
Jan 16, 2025
LG CHEM, LTD.
Sung Jae LEE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SYNTHESIS OF THE PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) RADIOLAB...
Publication number
20250019350
Publication date
Jan 16, 2025
Progenics Pharmaceuticals, Inc.
Pedro Benites
C07 - ORGANIC CHEMISTRY
Information
Patent Application
BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS
Publication number
20250019353
Publication date
Jan 16, 2025
ALBIREO AB
Per-Göran Gillberg
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES
Publication number
20250019360
Publication date
Jan 16, 2025
Elanco Animal Health GmbH
Dirk HEIMBACH
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6...
Publication number
20250019363
Publication date
Jan 16, 2025
Eli Lilly and Company
Aktham Aburub
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SALTS OF A PIM KINASE INHIBITOR
Publication number
20250019366
Publication date
Jan 16, 2025
INCYTE CORPORATION
Zhongjiang Jia
C07 - ORGANIC CHEMISTRY
Information
Patent Application
N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as CD38 i...
Publication number
20250019369
Publication date
Jan 16, 2025
Cerevance, Inc.
Roland Burli
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SMALL-MOLECULAR INHIBITORS FOR THE BETA-CATENIN/ B-CELL LYMPHOMA 9...
Publication number
20250019371
Publication date
Jan 16, 2025
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Haitao JI
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
Publication number
20250019374
Publication date
Jan 16, 2025
Calico Life Sciences LLC
Andrew Bogdan
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PYRROLE[2,3-B]PYRIDINE DERIVATIVES AS TYRO3 INHIBITORS
Publication number
20250019378
Publication date
Jan 16, 2025
Halia Therapeutics, Inc.
David James BEARSS
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NEW CRYSTAL FORM OF COMPOUND, AND PREPARATION METHOD THEREFOR AND U...
Publication number
20250019379
Publication date
Jan 16, 2025
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd
Pengfei LIU
C07 - ORGANIC CHEMISTRY
Information
Patent Application
2-Thioxothiazolidine-4-One Derivatives And Their Uses
Publication number
20250017910
Publication date
Jan 16, 2025
Prosetta Biosciences, Inc.
Kumarapandian Paulvannan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MODULATORS OF KV3 CHANNELS TO TREAT PAIN
Publication number
20250017925
Publication date
Jan 16, 2025
Autifony Therapeutics Limited
Charles LARGE
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
4H-IMIDAZO[1,5-B]PYRAZOLE DERIVATIVES FOR DIAGNOSIS
Publication number
20250018068
Publication date
Jan 16, 2025
AC IMMUNE SA
Jerome MOLETTE
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
(HET)ARYL SUBSTITUTED BISPHENOL COMPOUNDS AND THERMOPLASTIC RESINS
Publication number
20250019332
Publication date
Jan 16, 2025
REUTER CHEMISCHE APPARATEBAU e.K.
Vasyl ANDRUSHKO
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Crystal Modifications of Odevixibat
Publication number
20250019354
Publication date
Jan 16, 2025
ALBIREO AB
Robert Lundqvist
C07 - ORGANIC CHEMISTRY
Information
Patent Application
(3-QUINOLYL)-QUINAZOLINE
Publication number
20250019361
Publication date
Jan 16, 2025
BASF SE
Wassilios Grammenos
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Application
APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AN...
Publication number
20250019364
Publication date
Jan 16, 2025
ABBVIE INC.
Milan Bruncko
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Methods for Separation of Enantiomers
Publication number
20250019367
Publication date
Jan 16, 2025
Mirati Therapeutics, Inc.
Michal Achmatowicz
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Application
CRYSTALLINE FORMS OF A RIPK1 INHIBITOR
Publication number
20250019372
Publication date
Jan 16, 2025
Rigel Pharmaceuticals, Inc.
Shaoming DUAN
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CHROMANE AMIDINE MONOBACTAM ANTIBIOTICS
Publication number
20250019376
Publication date
Jan 16, 2025
Merck Sharp & Dohme LLC
Helen Y. Chen
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL INHIBITORS OF CYCLIN-DEPENDENT KINASES
Publication number
20250019382
Publication date
Jan 16, 2025
Origenis Gmbh
Roland Koestler
C07 - ORGANIC CHEMISTRY
Information
Patent Application
KRAS G12C INHIBITORS
Publication number
20250019387
Publication date
Jan 16, 2025
Frontier Medicines Corporation
Snahel PATEL
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COSMETIC COMPOUNDS
Publication number
20250017836
Publication date
Jan 16, 2025
TARA BRANDS EUROPE S.L.U.
Nawaf ARHAMAH
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
7,8-DIHYDRO-5H-1,6-NAPHTHYRIDINE DERIVATIVES AS POSITIVE ALLOSTERIC...
Publication number
20250017935
Publication date
Jan 16, 2025
Vanderbilt University
Craig W. Lindsley
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATE...
Publication number
20250017940
Publication date
Jan 16, 2025
NEW YORK UNIVERSITY
Rajesh KHANNA
G01 - MEASURING TESTING
Information
Patent Application
CRYSTALLINE FORMS OF TROFINETIDE
Publication number
20250019347
Publication date
Jan 16, 2025
ACADIA Pharmaceuticals Inc.
Matthew PETERSON
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SOLID PSILOCIN SALTS
Publication number
20250019348
Publication date
Jan 16, 2025
LOBE SCIENCES LTD.
Frederick SANCILIO
C07 - ORGANIC CHEMISTRY